These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 39030480)
41. Absolute quantification of serum microRNA-122 and its correlation with liver inflammation grade and serum alanine aminotransferase in chronic hepatitis C patients. Wang JH; Jiang D; Rao HY; Zhao JM; Wang Y; Wei L Int J Infect Dis; 2015 Jan; 30():52-6. PubMed ID: 25461662 [TBL] [Abstract][Full Text] [Related]
42. Evaluation of Serum Alpha-Fetoprotein Level in Chronic Hepatitis C Patients. Yang N; Li Z; Yan M; Xiao W; Zhang W; Long Y; Cheng Y; Ming K; Xu B Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775893 [TBL] [Abstract][Full Text] [Related]
43. Increased hepatic expression of miRNA-122 in patients infected with HCV genotype 3. Oliveira KG; Malta FM; Nastri AC; Widman A; Faria PL; Santana RA; Alves VA; Carrilho FJ; Pinho JR Med Microbiol Immunol; 2016 Apr; 205(2):111-7. PubMed ID: 26272127 [TBL] [Abstract][Full Text] [Related]
44. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C. Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561 [TBL] [Abstract][Full Text] [Related]
45. Micro-RNA-122 levels in acute liver failure and chronic hepatitis C. Dubin PH; Yuan H; Devine RK; Hynan LS; Jain MK; Lee WM; J Med Virol; 2014 Sep; 86(9):1507-14. PubMed ID: 24895202 [TBL] [Abstract][Full Text] [Related]
46. Clinical implications of alpha-fetoprotein in chronic hepatitis C. Tai WC; Hu TH; Wang JH; Hung CH; Lu SN; Changchien CS; Lee CM J Formos Med Assoc; 2009 Mar; 108(3):210-8. PubMed ID: 19293036 [TBL] [Abstract][Full Text] [Related]
47. Long-term treatment of chronic hepatitis C with ursodeoxycholic acid: influence of HCV genotypes and severity of liver disease. Lirussi F; Beccarello A; Bortolato L; Morselli-Labate AM; Crovatto M; Ceselli S; Santini G; Crepaldi G Liver; 1999 Oct; 19(5):381-8. PubMed ID: 10533795 [TBL] [Abstract][Full Text] [Related]
48. Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis? Park GJ; Lin BP; Ngu MC; Jones DB; Katelaris PH J Gastroenterol Hepatol; 2000 Apr; 15(4):386-90. PubMed ID: 10824882 [TBL] [Abstract][Full Text] [Related]
49. miR-34a promotes liver fibrosis in patients with chronic hepatitis via mediating Sirt1/p53 signaling pathway. Li X; Zhang W; Xu K; Lu J Pathol Res Pract; 2020 May; 216(5):152876. PubMed ID: 32089410 [TBL] [Abstract][Full Text] [Related]
50. [Oxidative stress in chronic hepatitis C patients]. Zhao J; Fan YC; Zhang F; Yang Y; Zhao ZH; Sun FK; Wang K Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Feb; 27(1):47-9. PubMed ID: 23855130 [TBL] [Abstract][Full Text] [Related]
52. Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection. Pohl A; Behling C; Oliver D; Kilani M; Monson P; Hassanein T Am J Gastroenterol; 2001 Nov; 96(11):3142-6. PubMed ID: 11721762 [TBL] [Abstract][Full Text] [Related]
53. Expression profiles of candidate microRNAs in the peripheral blood leukocytes of patients with early- and late-onset preeclampsia versus normal pregnancies. Demirer S; Hocaoglu M; Turgut A; Karateke A; Komurcu-Bayrak E Pregnancy Hypertens; 2020 Jan; 19():239-245. PubMed ID: 31899190 [TBL] [Abstract][Full Text] [Related]
54. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. Giannini E; Risso D; Botta F; Chiarbonello B; Fasoli A; Malfatti F; Romagnoli P; Testa E; Ceppa P; Testa R Arch Intern Med; 2003 Jan; 163(2):218-24. PubMed ID: 12546613 [TBL] [Abstract][Full Text] [Related]
55. Studying the association of microRNA-210 level with chronic hepatitis B progression. Song G; Jia H; Xu H; Liu W; Zhu H; Li S; Shi J; Li Z; He J; Chen Z J Viral Hepat; 2014 Apr; 21(4):272-80. PubMed ID: 24597695 [TBL] [Abstract][Full Text] [Related]
56. Circulating microRNAs as a biomarker to predict therapy efficacy in hepatitis C patients with different genotypes. Fan Z; Zhang Q; Chen H; He P; Li Y; Si M; Jiao X Microb Pathog; 2017 Nov; 112():320-326. PubMed ID: 28993299 [TBL] [Abstract][Full Text] [Related]
57. Serum MiRNA panel as potential biomarkers for chronic hepatitis B with persistently normal alanine aminotransferase. Tan Y; Ge G; Pan T; Wen D; Gan J Clin Chim Acta; 2015 Dec; 451(Pt B):232-9. PubMed ID: 26483130 [TBL] [Abstract][Full Text] [Related]
58. Circulating miRNA-192 and miR-29a as Disease Progression Biomarkers in Hepatitis C Patients with a Prevalence of HCV Genotype 3. Ullah A; Rehman IU; Ommer K; Ahmed N; Odenthal M; Yu X; Ahmad J; Nadeem T; Ali Q; Ahmad B Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239415 [TBL] [Abstract][Full Text] [Related]
59. Chronic hepatitis C virus infection: Relationships between inflammatory marker levels and compensated liver cirrhosis. Li X; Wang L; Gao P Medicine (Baltimore); 2019 Sep; 98(39):e17300. PubMed ID: 31574855 [TBL] [Abstract][Full Text] [Related]
60. Efficacy and safety of Chlorella supplementation in adults with chronic hepatitis C virus infection. Azocar J; Diaz A World J Gastroenterol; 2013 Feb; 19(7):1085-90. PubMed ID: 23467073 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]